Slide 1Amphotericin- or Echinocandin-Based Antifungal Prophylaxis Approaches Jo-Anne Young, MD, FACP, FIDSA Slide 2 Disclosures Clinical Trials funding support (antifungal…

Slide 1Paul E. Verweij, MD Department of Medical Microbiology Nijmegen University Center of Infectious Diseases, UMC St Radboud Advances in the diagnosis of invasive aspergillosis…

Slide 1Epidemiology & Risk Factors Adilia Warris, MD Nijmegen University Center of Infectious Diseases, UMC St Radboud Adilia Warris MD PhD Pediatric infectious diseases…

Slide 1The extraordinary spectrum of diseases caused by Aspergillus David W. Denning Wythenshawe Hospital University of Manchester Slide 2 The genus Aspergillus - importance…

Slide 1Getting to the diagnosis of aspergillosis: Tests and their interpretation David W. Denning Wythenshawe Hospital University of Manchester Slide 2 Spores inhaled Aspergillus…

1. The extraordinary spectrum of diseasescaused by Aspergillus David W. DenningWythenshawe Hospital University of Manchester 2. The genus Aspergillus - importance to humanity…

1. Fungal infections in hematology patients: advances in prophylaxis and treatment Vincent CC Cheng MBBS (HK), MD (HK), PDipID (HK), MCRP (UK), FRCPath (UK), FHKCPath, FHKAM…

Approaches to febrile neutropenia 2011 IDSA-ECIL guidelines Johan Maertens, MD, PhD Department of Hematology University Hospitals Leuven Leuven, Belgium Febrile Neutropenia:…

Slide 1Antifungal Prophylaxis in Solid Organ Transplant Recipients: Seeking Clarity Amidst Controversy Nina Singh, M.D. Slide 2 Rationalizing antifungal prophylaxis and strategies…

Slide 1www.icnarc.org Fungal Infection Risk Evaluation (FIRE) NIHR HTA: 07/29/01 NIHR CRN Portfolio Study ID: 7083 Better targeting of antifungal prophylaxis to improve care…